Re: Rationale and Design of Apabetalone BETonMACE Trial
in response to
by
posted on
Jun 01, 2019 07:32PM
Here's an example rationale and design paper for Amarin's REDUCE-IT trial for Vascepa.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5396348/